{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T21:04:27Z","timestamp":1789679067580,"version":"4.0.1"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82573612"],"award-info":[{"award-number":["82573612"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173850"],"award-info":[{"award-number":["82173850"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.bcp.2026.118468","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T23:18:40Z","timestamp":1789168720000},"page":"118468","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P2","title":["NPRA silencing overcomes TRAIL resistance via DR5 upregulation, anti-apoptotic factor inhibition, and NF-\u03baB pathway suppression in lung cancer"],"prefix":"10.1016","volume":"254","author":[{"given":"Yingying","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zelin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xudong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronghui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiubin","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyi","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1059-9400","authenticated-orcid":false,"given":"Zhengqiang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2026.118468_b0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bcp.2026.118468_b0010","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nature25183","article-title":"The biology and management of non-small cell lung cancer","volume":"553","author":"Herbst","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2026.118468_b0015","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14194562","article-title":"Current landscape of therapeutic resistance in lung cancer and promising strategies to overcome resistance","volume":"14","author":"Ashrafi","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.bcp.2026.118468_b0020","article-title":"Addressing clinical needs in NSCLC immunotherapy: mechanisms of resistance and promising combination strategies","volume":"6","author":"Kang","year":"2025","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.bcp.2026.118468_b0025","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.628332","article-title":"The TRAIL in the treatment of human cancer: an update on clinical trials","volume":"8","author":"Snajdauf","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.bcp.2026.118468_b0030","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1158\/1535-7163.MCT-21-0532","article-title":"Functional genomic identification of predictors of sensitivity and mechanisms of resistance to multivalent second-generation TRAIL-R2 agonists","volume":"21","author":"Grinkevitch","year":"2022","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bcp.2026.118468_b0035","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.7150\/thno.23880","article-title":"Endogenous IgG-based affinity-controlled release of TRAIL exerts superior antitumor effects","volume":"8","author":"Yang","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.bcp.2026.118468_b0040","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s10529-006-9300-7","article-title":"Biological and physicochemical evaluation of the conformational stability of tumor necrosis factor-related apoptosis-inducing ligand TRAIL","volume":"29","author":"Youn","year":"2007","journal-title":"Biotechnol. Lett"},{"key":"10.1016\/j.bcp.2026.118468_b0045","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2017.1265291","article-title":"TRAIL delivery by MSC-derived extracellular vesicles is an effective anticancer therapy","volume":"6","author":"Yuan","year":"2017","journal-title":"J. Extracell Vesicles."},{"key":"10.1016\/j.bcp.2026.118468_b0050","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s00109-022-02180-9","article-title":"EV-T synergizes with AZD5582 to overcome TRAIL resistance through concomitant suppression of cFLIP, MCL-1, and IAPs in hepatocarcinoma","volume":"100","author":"Su","year":"2022","journal-title":"J. Mol. Med. (Berl)"},{"key":"10.1016\/j.bcp.2026.118468_b0055","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12051157","article-title":"Extracellular vesicle delivery of TRAIL eradicates resistant tumor growth in combination with CDK inhibition by dinaciclib","volume":"12","author":"Ke","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bcp.2026.118468_b0060","doi-asserted-by":"crossref","DOI":"10.1186\/s12645-025-00329-y","article-title":"Exosomal encapsulation of a steviol derivative SD9 to overcome TRAIL resistance as a highly effective therapy against lung cancer","volume":"16","author":"Li","year":"2025","journal-title":"Cancer Nanotechnol."},{"key":"10.1016\/j.bcp.2026.118468_b0065","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41420-025-02656-w","article-title":"The role and clinical value of natriuretic peptide receptor family in malignant tumor","volume":"11","author":"Quan","year":"2025","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.bcp.2026.118468_b0070","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.693099","article-title":"Molecular signaling mechanisms and function of natriuretic peptide receptor-a in the pathophysiology of cardiovascular homeostasis","volume":"12","author":"Pandey","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.bcp.2026.118468_b0075","article-title":"Roles of natriuretic peptides and the significance of neprilysin in cardiovascular diseases","volume":"11","author":"Nakagawa","year":"2022","journal-title":"Biology (Basel)"},{"key":"10.1016\/j.bcp.2026.118468_b0080","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.pharmthera.2003.11.001","article-title":"Autocrine and paracrine actions of natriuretic peptides in the heart","volume":"101","author":"D'Souza","year":"2004","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bcp.2026.118468_b0085","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.cardiores.2006.07.006","article-title":"Antioxidant actions contribute to the antihypertrophic effects of atrial natriuretic peptide in neonatal rat cardiomyocytes","volume":"72","author":"Laskowski","year":"2006","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.bcp.2026.118468_b0090","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/s41419-021-04266-7","article-title":"Natriuretic peptide receptor a promotes gastric malignancy through angiogenesis process","volume":"12","author":"Li","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bcp.2026.118468_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2023.101734","article-title":"NPRA promotes fatty acid metabolism and proliferation of gastric cancer cells by binding to PPAR\u03b1","volume":"35","author":"Cao","year":"2023","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.bcp.2026.118468_b0100","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1158\/0008-5472.CAN-07-3086","article-title":"Natriuretic peptide receptor a as a novel anticancer target","volume":"68","author":"Kong","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2026.118468_b0105","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1007\/s12015-025-10979-5","article-title":"The advantages of mesenchymal stem cell-derived extracellular vesicles as drug delivery systems","volume":"21","author":"Kuang","year":"2025","journal-title":"Stem Cell Rev. Rep."},{"key":"10.1016\/j.bcp.2026.118468_b0110","doi-asserted-by":"crossref","first-page":"5873","DOI":"10.2147\/IJN.S506793","article-title":"Intranasal delivery of BACE1 siRNA and berberine via engineered stem cell exosomes for the treatment of Alzheimer's disease","volume":"20","author":"Sun","year":"2025","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.bcp.2026.118468_b0115","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12951-025-03900-2","article-title":"NUP85 siRNA loaded red blood cell-derived extracellular vesicles alleviate hepatic steatosis in MASLD","volume":"24","author":"Zhang","year":"2025","journal-title":"J Nanobiotechnol."},{"key":"10.1016\/j.bcp.2026.118468_b0120","article-title":"TRAIL\u2010Armed ER nanosomes induce drastically enhanced apoptosis in resistant tumor in combination with the antagonist of IAPs (AZD5582)","volume":"10","author":"Hou","year":"2021","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.bcp.2026.118468_b0125","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1039\/D1BM01751A","article-title":"Extracellular vesicle-mediated co-delivery of TRAIL and dinaciclib for targeted therapy of resistant tumors","volume":"10","author":"Ke","year":"2022","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.bcp.2026.118468_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.acthis.2022.151856","article-title":"Sensitizing TRAIL response via differential modulation of anti- and pro-apoptotic factors by AZD5582 combined with ER nanosomal TRAIL in neuroblastoma","volume":"124","author":"Huang","year":"2022","journal-title":"Acta Histochem."},{"key":"10.1016\/j.bcp.2026.118468_b0135","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.jcyt.2015.03.603","article-title":"Mesenchymal stromal cell delivery of full-length tumor necrosis factor\u2013related apoptosis-inducing ligand is superior to soluble type for cancer therapy","volume":"17","author":"Yuan","year":"2015","journal-title":"Cytotherapy"},{"key":"10.1016\/j.bcp.2026.118468_b0140","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1007\/s10495-023-01842-4","article-title":"Selective CDK9 knockdown sensitizes TRAIL response by suppression of antiapoptotic factors and NF-kappaB pathway","volume":"28","author":"Yuan","year":"2023","journal-title":"Apoptosis"},{"key":"10.1016\/j.bcp.2026.118468_b0145","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1210\/er.2005-0014","article-title":"Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions","volume":"27","author":"Dickey","year":"2006","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bcp.2026.118468_b0150","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.peptides.2004.09.024","article-title":"Biology of natriuretic peptides and their receptors","volume":"26","author":"Pandey","year":"2005","journal-title":"Peptides"},{"key":"10.1016\/j.bcp.2026.118468_b0155","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s00395-004-0460-0","article-title":"Molecular physiology of natriuretic peptide signalling","volume":"99","author":"Kuhn","year":"2004","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.bcp.2026.118468_b0160","doi-asserted-by":"crossref","first-page":"25892","DOI":"10.1074\/jbc.M000786200","article-title":"Activation of the particulate and not the soluble guanylate cyclase leads to the inhibition of Ca2+ extrusion through localized elevation of cGMP","volume":"275","author":"Zolle","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2026.118468_b0165","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1172\/JCI119883","article-title":"Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts","volume":"101","author":"Calderone","year":"1998","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.bcp.2026.118468_b0170","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nrm1983","article-title":"Regulation of cardiac hypertrophy by intracellular signalling pathways","volume":"7","author":"Heineke","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bcp.2026.118468_b0175","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.cardiores.2005.10.001","article-title":"The role of natriuretic peptides in cardioprotection","volume":"69","author":"Nishikimi","year":"2006","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bcp.2026.118468_b0180","first-page":"1415","article-title":"Natriuretic peptide receptor a promotes breast cancer development by upregulating MMP9","volume":"9","author":"Qu","year":"2019","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.bcp.2026.118468_b0185","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/1477-7819-12-154","article-title":"Expression of natriuretic peptide receptor-A in esophageal squamous cell carcinomas and the relationship with tumor invasion and migration","volume":"12","author":"Zhao","year":"2014","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.bcp.2026.118468_b0190","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1476-4598-10-56","article-title":"Natriuretic peptide receptor a as a novel target for prostate cancer","volume":"10","author":"Wang","year":"2011","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bcp.2026.118468_b0195","first-page":"3209","article-title":"Impact of NPR-A expression in gastric cancer cells","volume":"7","author":"Zhang","year":"2014","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.bcp.2026.118468_b0200","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.freeradbiomed.2016.08.019","article-title":"Natriuretic peptide receptor A inhibition suppresses gastric cancer development through reactive oxygen species-mediated G2\/M cell cycle arrest and cell death","volume":"99","author":"Li","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bcp.2026.118468_b0205","article-title":"Atrial natriuretic peptide (ANP) modulates stress-induced autophagy in endothelial cells","volume":"1872","author":"Forte","year":"2025","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bcp.2026.118468_b0210","doi-asserted-by":"crossref","first-page":"F806","DOI":"10.1152\/ajprenal.00394.2023","article-title":"Identification of natriuretic peptide receptor A-related gene expression signatures in podocytes in vivo reveals baseline control of protective pathways","volume":"327","author":"Jensen","year":"2024","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.bcp.2026.118468_b0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mce.2018.05.014","article-title":"Molecular mechanisms underlying the neuroprotective role of atrial natriuretic peptide in experimental acute ischemic stroke","volume":"472","author":"L\u00f3pez-Morales","year":"2018","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bcp.2026.118468_b0220","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41419-023-05696-1","article-title":"NRP1 promotes prostate cancer progression via modulating EGFR-dependent AKT pathway activation","volume":"14","author":"Zhang","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bcp.2026.118468_b0225","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.phymed.2015.12.017","article-title":"Sinapine reverses multi-drug resistance in MCF-7\/dox cancer cells by downregulating FGFR4\/FRS2\u03b1-ERK1\/2 pathway-mediated NF-\u03baB activation","volume":"23","author":"Guo","year":"2016","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bcp.2026.118468_b0230","doi-asserted-by":"crossref","first-page":"4147","DOI":"10.3892\/ol.2016.5136","article-title":"Resveratrol reverses P-glycoprotein-mediated multidrug resistance of U2OS\/ADR cells by suppressing the activation of the NF-\u03baB and p38 MAPK signaling pathways","volume":"12","author":"Zhang","year":"2016","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bcp.2026.118468_b0235","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1038\/s41416-020-0783-0","article-title":"Targeting CD133 reverses drug-resistance via the AKT\/NF-\u03baB\/MDR1 pathway in colorectal cancer","volume":"122","author":"Yuan","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bcp.2026.118468_b0240","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.21873\/anticanres.17667","article-title":"Resveratrol derivatives inhibit pro-survival Akt signaling pathway in lung cancer","volume":"45","author":"Innets","year":"2025","journal-title":"Anticancer Res"},{"key":"10.1016\/j.bcp.2026.118468_b0245","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1111\/j.1742-4658.2011.08114.x","article-title":"Natriuretic peptides and their receptors","volume":"278","author":"Misono","year":"2011","journal-title":"FEBS J."},{"key":"10.1016\/j.bcp.2026.118468_b0250","article-title":"Novel NPR2 gene mutations affect chondrocytes function via ER stress in short stature","volume":"11","author":"Li","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.bcp.2026.118468_b0255","article-title":"Novel loss-of-function mutations in NPR2 cause acromesomelic dysplasia, maroteaux type","volume":"13","author":"Wu","year":"2022","journal-title":"Front. Genet."},{"key":"10.1016\/j.bcp.2026.118468_b0260","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1159\/000492649","article-title":"Long noncoding RNA BCYRN1 promotes the proliferation of colorectal cancer cells via up-regulating NPR3 expression","volume":"48","author":"Gu","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.bcp.2026.118468_b0265","first-page":"629","article-title":"LncRNA FENDRR upregulation promotes hepatic carcinoma cells apoptosis by targeting miR-362-5p Via NPR3 and p38-MAPK pathway","volume":"35","author":"Qian","year":"2020","journal-title":"Cancer Biother. Radiopharm."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226008087?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226008087?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:24:20Z","timestamp":1789676660000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226008087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":53,"alternative-id":["S0006295226008087"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118468","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NPRA silencing overcomes TRAIL resistance via DR5 upregulation, anti-apoptotic factor inhibition, and NF-\u03baB pathway suppression in lung cancer","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118468","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118468"}}